Drug Topics
JULY 27, 2023
A new study found that 25%-46% of esophageal adenocarcinomas in patients with newly diagnosed Barrett’s esophagus were categorized as post-endoscopy esophageal adenocarcinoma.
Pharmacy Times
JULY 27, 2023
Further analysis shows that 300 mg lenacapvir tablets plus an optimized background regimen can effectively reconcile a missed dose of lenacapavir injection in patients with HIV.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 27, 2023
The National Rosacea Society found that a lack of health insurance or the high cost of a copay caused 52% of respondents to avoid obtaining medical care for their rosacea.
Pharmacy Times
JULY 27, 2023
Consuming a vegetarian diet lowered LDL-C, HbA1C, and body weight when compared to a usual diet, but did not significantly affect systolic blood pressure levels.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JULY 27, 2023
A minimum dose of 3.4 to 3.6 minutes of vigorous intermittent lifestyle physical activity per day was associated with a 17% to 18% reduction in total incident cancer risk.
Pharmacy Times
JULY 27, 2023
A study shows the first 2 years of life are a vital time to establish healthy sleep routines in infant children.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JULY 27, 2023
Rates of hospitalizations and mortality from COVID-19 were more than 4 times lower in 2022 compared to 2021, as the virus become less severe with new mutations, a recent study found.
Fierce Healthcare
JULY 27, 2023
Last month, the American Medical Association (AMA) passed a resolution to protect access to gender-affirming care, committing to opposing criminal and legal penalties against patients, their famili | Approved by Gov. Ron DeSantis, the law imposes restrictions on adult access to gender-affirming care. Some providers have been forced to stop serving new or existing patients in some capacity.
Pharmacy Times
JULY 27, 2023
Pembrolizumab is already indicated to treat patients with unresectable or metastatic melanoma, along with stage 2B-3 melanoma after resection in adults and pediatric patients.
STAT
JULY 27, 2023
To narrow the nation’s deeply entrenched health disparities, a permanent entity with regulatory powers should be created by the president to oversee health equity efforts across the entire federal government, says a report issued Thursday by the National Academies of Science, Engineering, and Medicine. In its many recommendations, the committee that wrote the report called for Congress to create a scorecard to assess how new federal legislation might affect health equity; urged all federa
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
JULY 27, 2023
Amazon Web Services announced Wednesday a new AI-powered service for healthcare software providers that will help clinicians with paperwork. | AWS HealthScribe uses generative AI and speech recognition to help doctors transcribe and analyze their conversations with patients and drafts clinical notes.
STAT
JULY 27, 2023
For many Americans, the warmer spring and summer months bring backyard barbecues and scenic hikes — along with a chorus of cicadas, mosquitoes galore, and hypervigilant self-checks for ticks. Often, insect bites only cause mild discomfort but new reports from the Centers for Disease Control and Prevention warn that a food allergy caused by ticks is on the rise in the U.S.
European Pharmaceutical Review
JULY 27, 2023
A paper published in ACS Synthetic Biology has demonstrated a novel method for storing biological materials such as RNA and proteins via solid-state storage. This would be as a pill or a tablet, which can be dissolved in water for on-demand use. The innovation by researchers at California Polytechnic State University in the US could help overcome current limitations in the storage and handling of products derived from living cells.
STAT
JULY 27, 2023
The handling of Senate Minority Leader Mitch McConnell’s abrupt medical issue this week is raising concerns among medical experts that the event sent a potentially dangerous public-health message — that when someone experiences an episode with symptoms like McConnell’s, they can simply return to work as though nothing had happened.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Checkup by Singlecare
JULY 27, 2023
When you’re pregnant, you already have to deal with morning sickness, swollen feet, and hormonal changes—but you’re also more likely to get motion sickness. It doesn’t seem fair, does it? Fortunately, the drug Dramamine, which relieves motion sickness, can also help with morning sickness during early pregnancy —and is considered safe for pregnancy. Here’s what you should know about taking Dramamine while pregnant.
STAT
JULY 27, 2023
It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S. This was the challenge, and the opportunity, faced by the team behind Opill, the landmark pill from drugmaker Perrigo that received approval from the Food and Drug Administration earlier this month.
pharmaphorum
JULY 27, 2023
Merck, Moderna start phase 3 trial of mRNA cancer jab Phil.
STAT
JULY 27, 2023
New breast cancer screening guidelines from the United States Preventive Services Task Force give the impression that the decades-long debate over when women should start getting mammograms is settled. The agency now recommends beginning at age 40 , reversing the age-50 guideline that had been in place since 2009. This change aligns it with other expert organizations such as the American College of Radiology (though the two still differ on whether women should get mammograms annually or every tw
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
European Pharmaceutical Review
JULY 27, 2023
ENHERTU ® (trastuzumab deruxtecan) has demonstrated clinically meaningful progression-free survival (PFS) and overall survival (OS) in topline results from the primary analysis of the ongoing DESTINY-PanTumor02 Phase II trial. The data was for previously treated patients across multiple HER2 expressing advanced solid tumours, two secondary endpoints.
STAT
JULY 27, 2023
WASHINGTON – The Food and Drug Administration says it needs Congress to give it more power to regulate CBD. Two powerful congressional Republicans made clear Thursday that they aren’t willing to do that. GOP leaders on the House Oversight Committee blasted the FDA during a hearing Thursday for the ask , insisting that the FDA can, and should, regulate these products like it would any other dietary supplement or food additive.
Pharma Marketing Network
JULY 27, 2023
Developing strong and meaningful relationships with Healthcare Professionals (HCPs) is vital for healthcare organizations, pharmaceutical companies, and medical device manufacturers alike. These partnerships not only improve patient outcomes but also foster mutual trust and collaboration. In this blog, we will explore five effective strategies to enhance your relationship-building efforts with HCPs and ultimately achieve better healthcare outcomes.
STAT
JULY 27, 2023
WASHINGTON — President Biden’s administration on Thursday announced the first cancer-focused initiative under its advanced health research agency, aiming to help doctors more easily distinguish between cancerous cells and healthy tissue during surgery and improve outcomes for patients. The administration’s Advanced Research Projects Agency for Health, or ARPA-H , is launching a Precision Surgical Interventions program, seeking ideas from the public and private sectors
pharmaphorum
JULY 27, 2023
Headspace raise leads flurry of digital health financings Phil.
STAT
JULY 27, 2023
Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest. The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans.
pharmaphorum
JULY 27, 2023
Enhertu shows survival boost in HER2+ solid tumours Phil.
STAT
JULY 27, 2023
WASHINGTON — Republicans on Thursday sought to turn around transgender advocates’ arguments that gender-affirming care is a personal health care decision. The LGBTQ+ community has long pressed Democrats to frame their defense of transgender rights, and particularly gender-affirming care for minors, as a basic right for a person to pursue with their medical providers — and that conservative bans on access represent hypocrisy from traditionally small-government Republicans.
pharmaphorum
JULY 27, 2023
Medicxi primes its latest $400m biotech fund Phil.
STAT
JULY 27, 2023
The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis. Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iver
Drug Store News
JULY 27, 2023
Giant’s dietitian team offers meal and snack inspiration to save customers time, energy and money this back-to-school season.
STAT
JULY 27, 2023
Top of the morning to you. And a steamy one, it is. In fact, there is more steam rising from the grounds of the Pharmalot campus than from our ritual cup of stimulation — our choice today is blueberry cobbler. But this is to be expected at this time of year, yes? In any event, there is work to be done, so as always, we have assembled a few items of interest for you.
European Pharmaceutical Review
JULY 27, 2023
The first targeted therapy approved for paediatric patients with generalised myasthenia gravis (gMG) has been approved in the EU. Soliris (eculizumab) has been authorised for expanded use in children and adolescents aged six to 17 years who are anti-acetylcholine receptor (AChR) antibody-positive (Ab+). This decision by the European Commission (EC) follows the positive opinion of the Committee for Medicinal Products for Human Use (CHMP).
STAT
JULY 27, 2023
The chief executive of the country’s biggest hospital chain said Thursday that labor costs are now lower as a percent of revenue than they were before the pandemic. “And again, that’s in the face of a very difficult labor market,” HCA Healthcare CEO Sam Hazen noted on the company’s second quarter earnings call. Health care providers and insurers are in the full swing of releasing their second-quarter earnings, and HCA tends to outperform its peers.
pharmaphorum
JULY 27, 2023
Oncotype DX: Breast cancer, genomics, and rethinking the oncology paradigm Mike.
Expert insights. Personalized for you.
247 
Let's personalize your content